Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Colorcon
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Methyl beta-galactoside

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Methyl beta-galactoside: Sponsors, patents, clinical trial progress

Methyl beta-galactoside is an investigational drug.

There have been 16 clinical trials for Methyl beta-galactoside. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2011.

The most common disease conditions in clinical trials are Cardiovascular Diseases, Anemia, Sickle Cell, and Aphasia, Primary Progressive. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), and Children's Mercy Hospital Kansas City.

There are sixty-seven US patents protecting this investigational drug and five hundred and fifty-five international patents.

Recent Clinical Trials for Methyl beta-galactoside
TitleSponsorPhase
Prolotherapy Versus Cortisone Injections for Partial Rotator Cuff TearsHadassah Medical OrganizationPhase 2
Treatment of Renal Stones With Frankincense (Luban)Sultan Qaboos UniversityPhase 1/Phase 2
Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal IntubationGhada Mohammed AboelFadlPhase 2/Phase 3

See all Methyl beta-galactoside clinical trials

Clinical Trial Summary for Methyl beta-galactoside

Top disease conditions for Methyl beta-galactoside
Top clinical trial sponsors for Methyl beta-galactoside

See all Methyl beta-galactoside clinical trials

US Patents for Methyl beta-galactoside

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Methyl beta-galactoside   Start Trial Multifunctional (meth)acrylate manufacturing method TOAGOSEI CO., LTD. (Tokyo, JP)   Start Trial
Methyl beta-galactoside   Start Trial Method for producing (meth)acrylate TOAGOSEI CO., LTD (Tokyo, JP)   Start Trial
Methyl beta-galactoside   Start Trial Self-repairing polyurethane networks Clemson University (Clemson, SC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Methyl beta-galactoside

Drugname Country Document Number Estimated Expiration Related US Patent
Methyl beta-galactoside China 106029628 2034-04-16   Start Trial
Methyl beta-galactoside European Patent Office 3133058 2034-04-16   Start Trial
Methyl beta-galactoside Japan 6273539 2034-04-16   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Baxter
Dow
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.